ESTRO 2024 - Abstract Book

S2227

Clinical - Upper GI

ESTRO 2024

Keywords: Gastric, interobserver variability,

References:

1. Leong T, Smithers BM, Michael M, et al. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). BMC Cancer 2015;15:532. (In eng). DOI: 10.1186/s12885-015-1529-x. 2. Slagter AE, Jansen EPM, van Laarhoven HWM, et al. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer 2018;18(1):877. (In eng). DOI: 10.1186/s12885-018-4770-2. 3. Moretones C, León D, Navarro A, et al. Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer. A pilot prospective study. Clin Transl Oncol 2012;14(2):132-7. (In eng). DOI: 10.1007/s12094-012-0772-8. 4. Jansen EP, Nijkamp J, Gubanski M, Lind PA, Verheij M. Interobserver variation of clinical target volume delineation in gastric cancer. Int J Radiat Oncol Biol Phys 2010;77(4):1166-70. (In eng). DOI: 10.1016/j.ijrobp.2009.06.023. 5. Onal C, Cengiz M, Guler OC, Dolek Y, Ozkok S. The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer. Br J Radiol 2017;90(1073):20160826. (In eng). DOI: 10.1259/bjr.20160826. 6. Socha J, Wołąkiewicz G, Wasilewska - Teśluk E, et al. Clinical target volume in postoperative radiotherapy for gastric cancer: identification of major difficulties and controversies. Clin Transl Oncol 2016;18(5):480-8. (In eng). DOI: 10.1007/s12094-015-1396-6. 7. Li GC, Zhang Z, Ma XJ, et al. Variations in CT determination of target volume with active breath co-ordinate in radiotherapy for post-operative gastric cancer. Br J Radiol 2016;89(1058):20150332. (In eng). DOI: 10.1259/bjr.20150332. 8. Lukovic J, Moore AJ, Lee MT, et al. The Feasibility of Quality Assurance in the TOPGEAR International Phase III Clinical Trial of Neoadjuvant Chemoradiotherapy for Gastric Cancer (An Intergroup Trial of the AGITG/TROG/EORTC/CCTG). International Journal of Radiation Oncology*Biology*Physics 2021;111(3):S38-S39. DOI: 10.1016/j.ijrobp.2021.07.111. 9. A. Slagter MV, J. Buijsen, E. Hendriksen, M. Hulshof, S. Mook, K. Neelis, V. Oppedijk, T. Rozema, M. van der Sangen, E. Jansen. MO-0219 Quality assurance of preoperative radiotherapy in the CRITICS-II gastric cancer trial. ESTRO 20222022.

10. Borggreve AS, Goense L, Brenkman HJF, et al. Imaging strategies in the management of gastric cancer: current role and future potential of MRI. Br J Radiol 2019;92(1097):20181044. (In eng). DOI: 10.1259/bjr.20181044.